Fisher Wallace Laboratories, Inc. (0001787792) Files SEC Form, C-U Notification Issued
In a recent SEC filing, Fisher Wallace Laboratories, Inc. (0001787792) submitted a C-U form, indicating a change in the company’s control. The C-U form is typically filed when there is a shift in the ownership or control of a company. This could signal a significant development within Fisher Wallace Laboratories, such as a change in leadership or ownership structure. Investors and stakeholders may want to closely monitor further announcements from the company to understand the implications of this filing.
Fisher Wallace Laboratories, Inc. is a company that specializes in developing non-invasive medical devices for the treatment of mood and sleep disorders. Their flagship product, the Fisher Wallace Stimulator®, is FDA-cleared for the treatment of depression, anxiety, and insomnia. With a focus on innovative healthcare solutions, Fisher Wallace Laboratories aims to provide effective and accessible treatments for patients. For more information about Fisher Wallace Laboratories, Inc., you can visit their website here.
The C-U form filed by Fisher Wallace Laboratories, Inc. with the SEC signifies a notable event in the company’s operations, likely related to a change in control. Investors and industry observers will be keen on monitoring any updates or announcements from Fisher Wallace Laboratories to gain insights into the implications of this filing.
Read More:
Fisher Wallace Laboratories, Inc. (0001787792) Files SEC Form, Update on Company Filing
